Unlock instant, AI-driven research and patent intelligence for your innovation.
3-(3-(heteroaryl)-4-thiazolinone)-N-aryl benzamide compound and synthesis and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of aryl benzamide and thiazolinone, which is applied in the field of biomedicine and synthetic medicine to achieve good inhibitory and selective effects
Pending Publication Date: 2022-04-01
SHANGHAI HONGHENG BIOMEDICAL TECH CO LTD
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0091]
[0092] III-1 is a foamy white solid with a yield of 92%.
[0107] 13 C NMR (101MHz, CDCl 3 )δ171.34,166.98,151.35,148.17,145.35,141.72,139.18,135.18,129.30,128.51,126.70,125.01,121.10,116.63,105.54,62.58,51.26,39.59,33.98,30.32,29.69,28.01,26.05.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a 3-(3-(heteroaryl)-4-thiazolinone)-N-arylbenzamide compound or a pharmaceutically acceptable salt, and the compound belongs to a compound with a new structure. The invention further discloses application of the compound or the pharmaceutically acceptable salt or the pharmaceutical composition of the compound to treatment of osteosarcoma and other related diseases, and the compound or the pharmaceutically acceptable salt or the pharmaceutical composition of the compound has good inhibition and good selectivity to different cell lines. The invention also discloses a preparation method of the thiazolinone compound. The method has the advantage of being capable of synthesizing thiazolinone compounds with heterocyclic rings and aliphatic groups at 3 sites, which cannot be synthesized by a traditional synthesis route.
Description
technical field [0001] The invention belongs to the field of synthetic medicine and biomedicine, and mainly relates to a 3-(3-(heteroaryl)-4-thiazolinonyl)-N-arylbenzamide compound and its synthesis method and application. Background technique [0002] Osteosarcoma, also called osteosarcoma, is a malignant bone tumor that commonly occurs in adolescents or children under the age of 20 (Link MP: Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Cancer Treat Res 62:383-385, 1993.), according to the epidemiological study of osteosarcoma, it is the most common in children with malignant bone tumors, accounting for 5% of children's tumors. Osteosarcoma is still a disease with a high mortality rate of malignant tumors in children and adolescents, second only to lymphoma and brain cancer, but early detection and timely treatment have greatly improved the survival rate of the disease. [0003] Treatme...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.